Janus Research Fund (JAMRX)

Large-Cap Growth Utilizing Our Analysts' Best Ideas



Inception Date5/3/1993
NAV (As of 2/17/17)$43.19
Total Net Assets (As of 1/31/17)$4.43B
Annual Expense Ratio
(As of fiscal year end 9/30/16)
GROSS 0.94%
NET 0.94%

Performance (As of 12/31/16)
1 Year1.41%
3 Year6.77%
5 Year13.92%
10 Year8.25%
Morningstar (As of 1/31/17)
CategoryUS Fund Large Growth
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/19.

Quarterly Commentary - Q4 2016


U.S. stocks rallied toward the latter part of the period on improving growth expectations.

The Fund underperformed its benchmark, weighed down, in part, by its health care and technology holdings.

We believe that in 2017 investors will shift their focus to company fundamentals and security selection will take on greater importance in driving returns.